- Biological heart valves
- Mechanical heart valves
- Transcatheter heart valves
Prosthetic Heart Valve Market size was valued at USD 6,815.2 million in 2022 and is poised to grow at a significant CAGR of 11.9% from 2023 - 2029. The four chambers of the human heart each have a valve to guarantee that blood only flows in one direction. The blood flows back into the atria or ventricles if any of the heart valves are leaking, constricted, swollen, or ruptured, placing extreme strain on the entire heart. The worst-case scenario here could result in arrhythmia or possibly heart failure. Prosthetic heart valves can be installed to fix the issue, depending on the defect's severity. Due to the aging population, lack of physical activity, and bad diet, demand for this sort of surgery is predicted to increase dramatically over the next few decades in many regions worldwide. In 2050, around 850,000 people will need mechanical heart valves. Furthermore, according to the World Health Organization, about 2% of patients with cardiovascular diseases (CVDs) have rheumatic heart disorders. Therefore, the market is projected to benefit in the years to come from the rise of rheumatic heart disorders. Additionally, the hunt for an alternative to the replacement heart valves already in use began in 2019 by researchers at ETH Zurich and the South African business SAT. And with some success: they designed a silicone prosthetic heart valve that is produced using 3D printers in several processes.
Prosthetic Heart Valve Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
11.9%
Largest Market
Asia Pacific
Fastest Growing Market
North America
Prosthetic Heart Valve Market Dynamics
Several healthcare facilities are using new and enhanced technology to give patients better therapies, drugs, and treatments since the healthcare system is rapidly evolving. Numerous government initiatives strongly support these advancements. The Prosthetic heart valve market is expanding, and this trend is projected to continue due to various payment methods and flexible insurance claims. Furthermore, data is crucial for properly developing and designing heart valves. Players in the market create the highest caliber valves with vital hospital data. Manufacturers are creating smart and intelligent heart valves using data-driven technologies like the Internet of Things and Prosthetic intelligence. In the upcoming years, market growth is anticipated to be driven by the swift adoption of data-driven technologies. However, the Prosthetic valve's high price and risk associated with replacement may constrain the market.
North-America Got Significant Share
Prosthetic Heart Valve Market Regional Analysis
The prosthetic heart valve market in North America is likely to hold a significant revenue share in 2021, and in the following years, it is predicted to increase rapidly. This is due to prominent players operating in these nations, a well-developed healthcare infrastructure, attractive reimbursement regulations, and other factors. Additionally, it is anticipated that rising expansion activities through strategic mergers and acquisitions for customer base expansion and technical developments would further boost the growth of the target market in this area.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Prosthetic Heart Valve Market Segmentation
By Product Type
By Geography
- North America
- Europe
- The Asia Pacific
- Latin America
- MEA
Frequently Asked Questions
The prosthetic heart valve market size was valued at USD 6,815.2 million in 2022
Edwards Lifesciences, Medtronic, Abbott, Boston Scientific Corporation, LivaNova, Symetis, Jenavalve Technology
The prosthetic heart valve market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1. Executive Summary |
| 2. Global Prosthetic Heart Valve Market Introduction |
| 2.1.Global Prosthetic Heart Valve Market - Taxonomy |
| 2.2.Global Prosthetic Heart Valve Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Geography |
| 2.2.3.Region |
| 3. Global Prosthetic Heart Valve Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Prosthetic Heart Valve Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Prosthetic Heart Valve Market By Product Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Biological heart valves |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Mechanical heart valves |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Transcatheter heart valves |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Prosthetic Heart Valve Market By Geography, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. North America |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Europe |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. The Asia Pacific |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Latin America |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. MEA |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Prosthetic Heart Valve Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. North America Prosthetic Heart Valve Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Biological heart valves |
| 8.1.2.Mechanical heart valves |
| 8.1.3.Transcatheter heart valves |
| 8.2. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.North America |
| 8.2.2.Europe |
| 8.2.3.The Asia Pacific |
| 8.2.4.Latin America |
| 8.2.5.MEA |
| 8.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9. Europe Prosthetic Heart Valve Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Biological heart valves |
| 9.1.2.Mechanical heart valves |
| 9.1.3.Transcatheter heart valves |
| 9.2. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.North America |
| 9.2.2.Europe |
| 9.2.3.The Asia Pacific |
| 9.2.4.Latin America |
| 9.2.5.MEA |
| 9.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 9.3.7. |
| 10. Asia Pacific (APAC) Prosthetic Heart Valve Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Biological heart valves |
| 10.1.2.Mechanical heart valves |
| 10.1.3.Transcatheter heart valves |
| 10.2. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.North America |
| 10.2.2.Europe |
| 10.2.3.The Asia Pacific |
| 10.2.4.Latin America |
| 10.2.5.MEA |
| 10.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11. Middle East and Africa (MEA) Prosthetic Heart Valve Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Biological heart valves |
| 11.1.2.Mechanical heart valves |
| 11.1.3.Transcatheter heart valves |
| 11.2. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.North America |
| 11.2.2.Europe |
| 11.2.3.The Asia Pacific |
| 11.2.4.Latin America |
| 11.2.5.MEA |
| 11.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12. Latin America Prosthetic Heart Valve Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Biological heart valves |
| 12.1.2.Mechanical heart valves |
| 12.1.3.Transcatheter heart valves |
| 12.2. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.North America |
| 12.2.2.Europe |
| 12.2.3.The Asia Pacific |
| 12.2.4.Latin America |
| 12.2.5.MEA |
| 12.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Edwards Lifesciences |
| 13.2.2.Medtronic |
| 13.2.3.Abbott |
| 13.2.4.Boston Scientific Corporation |
| 13.2.5.LivaNova |
| 13.2.6.Symetis |
| 13.2.7.Jenavalve Technology |
| 13.2.8.Cryolife |
| 13.2.9.TTK Healthcare Limited |
| 13.2.10.Colibri Heart Valve |
| 13.2.11.Lepu Medical Technology |
| 13.2.12.Braile Biom dica |
| 13.2.13.Micro Interventional |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
- Edwards Lifesciences
- Medtronic
- Abbott
- Boston Scientific Corporation
- LivaNova
- Symetis
- Jenavalve Technology
- Cryolife
- TTK Healthcare Limited
- Colibri Heart Valve
- Lepu Medical Technology
- Braile Biom dica
- Micro Interventional